Pure Global

Thrombomodulin Detection Kit (Chemiluminescent Immunoassay Method) - NMPA Registration 苏械注准20242402224

Access comprehensive regulatory information for Thrombomodulin Detection Kit (Chemiluminescent Immunoassay Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 苏械注准20242402224 and owned by Suzhou Lihe Biomedical Engineering Co., Ltd.. The device was approved on November 27, 2024.

This page provides complete registration details including registrant information, province location (Jiangsu), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.

Free Database
Powered by Pure Global AI
NMPA Official Data
Class II
苏械注准20242402224
Thrombomodulin Detection Kit (Chemiluminescent Immunoassay Method)
血栓调节蛋白测定试剂盒(化学发光免疫分析法)
NMPA Registration Number: 苏械注准20242402224
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Use
English

用于体外定量测定人血浆中血栓调节蛋白(TM)的含量.

中文

用于体外定量测定人血浆中血栓调节蛋白(TM)的含量。

Device Classification
Device Class
Class II
Model Specifications
50人份/盒,100人份/盒,200人份/盒.质控品1:1×1ml(选配),质控品2:1×1ml(选配)
50人份/盒,100人份/盒,200人份/盒。质控品1:1×1ml(选配),质控品2:1×1ml(选配)
Approval Department
Jiangsu Provincial Drug Administration
江苏省药品监督管理局
Registration Information
Registration Number
苏械注准20242402224
Approval Date
November 27, 2024
Expiry Date
November 26, 2029
Registrant
Name
Suzhou Lihe Biomedical Engineering Co., Ltd.
苏州立禾生物医学工程有限公司
Province/Region
Jiangsu
江苏
Address
Room 501, Building B11, Bionanopark, No. 218 Xinghu Street, Suzhou Industrial Park
苏州工业园区星湖街218号生物纳米园B11号楼501室
Production Facility
Production Address
苏州市工业园区赵家上路7号
Structure and Composition
English

试剂1:含生物素标记的血栓调节蛋白特异性单克隆抗体①(约0.5mg/L,鼠源性),0.05M Tris缓冲液,pH7.4(含1%牛血清白蛋白,0.1% proclin 300);试剂2:含吖啶酯标记的血栓调节蛋白单克隆抗体②(约0.5mg/L,鼠源性),0.05M Tris缓冲液,pH7.4(含1%牛血清白蛋白,0.1% proclin 300);试剂M:含链霉亲和素包被的磁颗粒(约0.3mg/mL),含0.1% proclin 300;系列校准品:含血栓调节蛋白抗原(重组蛋白,CHO),0.01M磷酸盐蛋白缓冲液(0.1% Proclin300);浓度分别约为0 TU/mL、2.0TU/mL、4.0 TU/mL、20.0TU/mL、100.0 TU/mL、200.0TU/mL;质控品1:含血栓调节蛋白抗原(重组蛋白,CHO)约4.0 TU/mL,0.1M磷酸盐蛋白缓冲液(含0.1% proclin 300);质控品2:含血栓调节蛋白抗原(重组蛋白,CHO)约20.0 TU/mL,0.1M磷酸盐蛋白缓冲液(含0.1% proclin 300);刺穿工具1个:用于试剂瓶盖的穿刺使用.二维码标签:含试剂信息、校准品浓度、预制校准曲线(两点定标时启用);

中文

试剂1:含生物素标记的血栓调节蛋白特异性单克隆抗体①(约0.5mg/L,鼠源性),0.05M Tris缓冲液,pH7.4(含1%牛血清白蛋白,0.1% proclin 300);试剂2:含吖啶酯标记的血栓调节蛋白单克隆抗体②(约0.5mg/L,鼠源性),0.05M Tris缓冲液,pH7.4(含1%牛血清白蛋白,0.1% proclin 300);试剂M:含链霉亲和素包被的磁颗粒(约0.3mg/mL),含0.1% proclin 300;系列校准品:含血栓调节蛋白抗原(重组蛋白,CHO),0.01M磷酸盐蛋白缓冲液(0.1% Proclin300);浓度分别约为0 TU/mL、2.0TU/mL、4.0 TU/mL、20.0TU/mL、100.0 TU/mL、200.0TU/mL;质控品1:含血栓调节蛋白抗原(重组蛋白,CHO)约4.0 TU/mL,0.1M磷酸盐蛋白缓冲液(含0.1% proclin 300);质控品2:含血栓调节蛋白抗原(重组蛋白,CHO)约20.0 TU/mL,0.1M磷酸盐蛋白缓冲液(含0.1% proclin 300);刺穿工具1个:用于试剂瓶盖的穿刺使用。二维码标签:含试剂信息、校准品浓度、预制校准曲线(两点定标时启用);

Storage Conditions and Expiration
English

未开封的试剂、校准品及质控品2-8℃环境下储存,有效期18个月;开瓶的试剂及校准品,2-8℃环境下可稳定保存60天.开封的质控品,2-8℃环境下可稳定保存60天.

中文

未开封的试剂、校准品及质控品2-8℃环境下储存,有效期18个月;开瓶的试剂及校准品,2-8℃环境下可稳定保存60天。开封的质控品,2-8℃环境下可稳定保存60天。

Additional Information
Appendix
产品技术要求、说明书